Noncovalent SARS-CoV-2 main protease inhibitors targeting the catalytic dyad and primed substrate binding subsites
Authors:
- Dipendra BhandariDBDipendra Bhandari
- Katerina KovalevskayaKKKaterina Kovalevskaya
- Leighton CoatesLCLeighton Coates
- Colleen B. JonssonCJColleen B. Jonsson
- Jyothi ParvathareddyJPJyothi Parvathareddy
- Kevin L. WeissKWKevin L. Weiss
- Annie AnianaAAAnnie Aniana
- John M. LouisJLJohn M. Louis
- Peter V. BonnesenPBPeter V. Bonnesen
- Andrey KovalevskyAKAndrey Kovalevsky
Open Access
- 1 September 2026
- journal article
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (9) , 4483-4501
Abstract
Novel noncovalent SARS-CoV-2 main protease inhibitors were designed, targeting catalytic dyad and primed binding subsites. Neutron diffraction revealed new conventional and nonconventional interactions, offering insights for future inhibitor design.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (DK075166-01)
- National Institutes of Health
This publication has 93 references indexed in Scilit:
- What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under MonitoringJAMA, 2026
- The Application of Deuteration Strategy in Drug DesignChemMedChem, 2025
- Non-peptidic inhibitors targeting SARS-CoV-2 main protease: A reviewBioorganic Chemistry, 2024
- Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitorsActa Pharmaceutica Sinica B, 2023
- Synthesis of deuterated S-217622 (Ensitrelvir) with antiviral activity against coronaviruses including SARS-CoV-2Antiviral Research, 2023
- The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizationsMedicinal Chemistry Research, 2022
- Cardiovascular disease in SARS‐CoV‐2 infectionClinical & Translational Immunology, 2021
- The macromolecular neutron diffractometer at the spallation neutron source2020
- Current developments in Coot for macromolecular model building of Electron Cryo‐microscopy and Crystallographic DataProtein Science, 2019
- Viral cysteine proteinasesPerspectives in Drug Discovery and Design, 1996